M&A in the pharmaceutical industry: the impact of target’s development of orphan drugs on acquisition premium and returns.

Additional Metadata
Keywords	pharma, m&a, acquisition premium, CARs, orphan drugs
Thesis Advisor	Ahmad, Farooq, Rajamani, Anjana
Persistent URL	hdl.handle.net/2105/56099
Series	Finance & Investments
Organisation	Rotterdam School of Management
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ferrari, Chiara. (2021, January 14). M&A in the pharmaceutical industry: the impact of target’s development of orphan drugs on acquisition premium and returns.. Finance & Investments. Retrieved from http://hdl.handle.net/2105/56099

Publication